Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07196072
What this trial is testing

A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain

Who this might be right for
SLE (Systemic Lupus)Chronic Pain
University of Michigan 15
Not applicableLooking for participantsNCT07397728
What this trial is testing

" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
South Valley University 90
Early research (Phase 1)Study completedNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Large-scale testing (Phase 3)WithdrawnNCT00382837
What this trial is testing

Study of Epratuzumab in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableStudy completedNCT00342329
What this trial is testing

Lupus Nephritis: Role of Environmental and Occupational Exposures

Who this might be right for
Lupus Nephritis
National Institute of Environmental Health Sciences (NIEHS)
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Testing effectiveness (Phase 2)Study completedNCT00547365
What this trial is testing

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
University of Tennessee 10
Early research (Phase 1)Looking for participantsNCT06801119
What this trial is testing

Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

Who this might be right for
Systemic Lupus ErythematosusSclerodermaRheumatoid Arthritis
Shenzhen MagicRNA Biotechnology Co., Ltd 30
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Early research (Phase 1)Study completedNCT02808793
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Who this might be right for
Indolent Systemic Mastocytosis
Allakos Inc. 25
Large-scale testing (Phase 3)Study completedNCT00429377
What this trial is testing

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Who this might be right for
Lupus Nephritis
Astellas Pharma Inc 64
Early research (Phase 1)Study completedNCT01687309
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 19
Not applicableStudy completedNCT03942263
What this trial is testing

Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

Who this might be right for
Hodgkin DiseaseLymphoma, Large-cell, Anaplastic
Takeda 2,000
Post-approval studies (Phase 4)Study completedNCT04515719
What this trial is testing

Efficacy and Safety of Belimumab in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 231
Not applicableStudy completedNCT03058328
What this trial is testing

The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.

Who this might be right for
Neuroinflammation
Karolinska University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04058028
What this trial is testing

Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Amgen 244
Not applicableStudy completedNCT04533971
What this trial is testing

The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (ICD10-G35)
Pomeranian Medical University Szczecin 114
Not applicableStudy completedNCT06046534
What this trial is testing

Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 46
Not applicableActive Not RecruitingNCT07203157
What this trial is testing

HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 20
Next Page